Organigram Holdings Inc. (NASDAQ: OGI) Q3 2022 earnings call dated Jul. 14, 2022 Corporate Participants: Craig MacPhail -- Group Director Beena Goldenberg -- Chief Executive Officer
OrganiGram Holdings Inc
-(OGI)
XNAS:OGI
Organigram Holdings Inc. (OGI) Q2 2022 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ: OGI) Q2 2022 earnings call dated Apr. 12, 2022 Corporate Participants: Craig MacPhail -- Group Director Beena Goldenberg -- Chief Executive Officer
Organigram Holdings, Inc. (OGI) Q1 2022 Earnings Call Transcript
Organigram Holdings, Inc. (NASDAQ: OGI) Q1 2022 earnings call dated Jan. 11, 2022 Corporate Participants: Beena Goldenberg -- Chief Executive Officer Derrick West -- Chief Financial
Favorable Cannabis Act review will amplify edibles demand: OrganiGram CEO Greg Engel
OrganiGram (NASDAQ: OGI) had trailed its Canadian rivals in expanding its geographic presence through strategic partnerships, till it finally established an alliance
Organigram Holdings Inc.(OGI) Q2 2021 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ: OGI) Q2 2021 earnings call dated Apr. 13, 2021. Corporate Participants: Amy Schwalm -- Vice President, Investor Relations
Organigram (NASDAQ: OGI) Q1 2020 Earnings Snapshot
-- Organigram Holdings Inc. (NASDAQ: OGI) reported a net loss from continuing operations of $9 million for the first quarter of 2020,
Organigram (NASDAQ: OGI) Q4 2019 Earnings Snapshot
-- Organigram (NASDAQ: OGI) reported a net loss from continuing operations of $22.46 million for the fourth quarter of 2019, vs. profit